Seeking Alpha

underdawg's  Instablog

underdawg
Send Message
Back To underdawg's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (10)
Track new comments
  • thresherfailed
    , contributor
    Comments (20) | Send Message
     
    You can't be serious.

     

    What happened to the real underdawg and his blogs?
    3 Sep 2013, 01:00 PM Reply Like
  • poor50boy
    , contributor
    Comments (4) | Send Message
     
    It seems that the cancer drug/ cancer diagnostic market is a hotbed of activity at the moment- mergers, expansion, new innovative testing procedures, approved drugs, failed drugs etc. Yet RXPC seems to be able to stay completely out of sight from the public eye. While I believe an upcoming merger/takeover is the primary reason for this blackout period, the complete lack of public acknowledgment is still troublesome.

     

    What happened with the William Gartner/ GCDx LC test- money and/ or patent issues delaying reverse takeover?

     

    What happened with the Uni-Pharma licensing agreement- dead in the water intentionally or??? Thanks in advance.
    6 Sep 2013, 09:54 AM Reply Like
  • thresherfailed
    , contributor
    Comments (20) | Send Message
     
    Do you believe the MJ rumor, underdawg?
    2 Apr, 11:27 AM Reply Like
  • thresherfailed
    , contributor
    Comments (20) | Send Message
     
    OK, so you don't believe the MJ rumor, which is a pity since it was the only chance, albeit slim, that you might have gotten some of your money back here.

     

    You've pumped a "creeping backdoor merger" for three years while the PPS fell from $30 to 0.0001. But now you're switching the pump from merger to Reorganization, correct?

     

    We're all ears. We're gathered around the campfire. Let's hear how this company could possibly Reorganize without filing for bankruptcy protection. Let's list their assets. Their last patent for onko-sure expires on June 3rd, 2014. What will they have left after that?
    27 Apr, 09:55 AM Reply Like
  • thresherfailed
    , contributor
    Comments (20) | Send Message
     
    I'm disappointed that you're not updating this blog, Underdawg. I want to hear how Provista is taking over Radient and paying off Radient's debt. I think Provista shareholders would like to hear how their money is being funneled into Radient, even though Radient's last patent for DR70 has now expired and Radient filed an 8K stating that they executed an Offer of Settlement with the Securities and Exchange Commission ("Commission") pursuant to Section 12(j) of the Securities Exchange Act of 1934, revoking the registration of the Company's securities.

     

    Yes, if I were a Provista shareholder, I'd want Provista management to (a) explain why being involved with Radient is a good idea or (b) publicly refute this rumor.
    11 Jun, 09:37 AM Reply Like
  • poor50boy
    , contributor
    Comments (4) | Send Message
     
    Now that Radient has its stock revoked by the SEC, is the William Gartner/ PDx reverse merger still proceeding as planned?

     

    Do you believe the new Radient management will keep its shareholders updated as to current developments, or in the dark as prior management did?

     

    Underdawg, do you plan on expanding this forum to provide an active blog for existing shareholders to state their views to one another- the current IHub and Yahoo messageboards have become rather useless in recent months. It would be nice to see more objective viewpoints.
    4 Jul, 12:17 PM Reply Like
  • thresherfailed
    , contributor
    Comments (20) | Send Message
     
    poor50boy (dcspka), there never will be a reverse merger. That was just a rumor started in 2011 when the wheels starting coming off the wagon. I don't think Provista shareholders appreciated this rumor in the past, but I guess it's harmless enough now, considering the events of the past two weeks.

     

    With RXPC security registration revoked and the patent receiving a final rejection, this company now has zero assets and many $$$ millions in debt that will never be repaid. This ticker will never trade again. It's over. The patent lawyers withdrew and I suggest you do the same.

     

    On the other hand, I too would like to see Underdawg (guardiangel) update this pump and see him try to explain why this ticker is not 100% dead, just for the entertainment value. That would be amusing. Underdawg, what say you?
    5 Jul, 11:57 AM Reply Like
  • poor50boy
    , contributor
    Comments (4) | Send Message
     
    I would say that you are incorrect in your assumptions that there is no takeover of Radient occurring, and that the debt load has not been addressed thru prior agreement between the Lenders and Takeover Group.

     

    While the revocation has pushed the timeline back, this is not an irrevocable problem, and Radient can be expected to emerge as a stronger, debt free company.
    6 Jul, 08:39 AM Reply Like
  • thresherfailed
    , contributor
    Comments (20) | Send Message
     
    poor50boy, you are the one making assumptions, not me. I am basing my opinion on the SEC filings and the USPTO transaction history and nothing more. You are basing YOUR opinions on wishful thinking and press releases from 2010. That approach has resulted in your watching your RXPC investment drop from $30 per share to the final result of zero per share. You might as well lift the bar and step out of the roller coaster car now because you've reached the end of the track and the ride has been shut down by the SEC.
    6 Jul, 07:54 PM Reply Like
  • thresherfailed
    , contributor
    Comments (20) | Send Message
     
    guardiangel, when are you going to update this blog? I am staying tuned to see how Radient Pharmaceuticals is controlling the Global Cancer Diagnostics market behind the scenes, and what the few remaining shareholders will get as a cash distribution / shares of the new company from the upcoming merger!

     

    Because frankly, it looks like Radient Pharmaceuticals isn't even controlling themselves -- the Delaware corporation is now void. Their last-chance patent application received a final rejection and the RXPC registration is revoked. If there ever WAS an upcoming merger (a dubious claim at best), there certainly isn't one now, you understand.
    17 Aug, 10:46 AM Reply Like
Full index of posts »
Latest Followers

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.